Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg ...Middle East

LONDON, Jan. 14, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of KLOXXADO® naloxone HCl nasal spray 8 mg in the U.S....

Hence then, the article about hikma announces exclusive commercial partnership with emergent biosolutions for kloxxado naloxone hcl nasal spray 8 mg was published today ( Tuesday 14/01/2025 - 03:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg )

Also on site :

• My Kid Is Now Banned From All Family Functions Until Further Notice. He Doesn’t Deserve This!
• Zelensky’s favorite drone company at center of Ukrainian corruption alert
• JPMorgan exec accused of making subordinate her ‘office sex slave’ – The Sun